Skip to main content
. 2019 Oct 4;23(10):496–507. doi: 10.1089/omi.2019.0122

FIG. 2.

FIG. 2.

Effects of efavirenz and rifampicin on mRNA expression of genes coding for drug-metabolizing enzymes or nuclear receptors in HepaRG cells (average of three biological replicates) relative to TBP as reference gene. Differentiated HepaRG cells were treated with efavirenz (6.4 μM), rifampicin (24.4 μM), or DMSO (0.02%) for 24 h. Expression of mRNA for genes coding for drug-metabolizing enzymes or nuclear receptors, in triplicate, were assessed by using qPCR and the fold change in mRNA expression is compared for each treatment condition. Significant (p < 0.05) changes in mRNA expression are indicated with *.